Study of BAY1834942 in Patients With Solid Tumors
NCT03596372
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced CEACAM6-expressing Solid Tumors
Interventions
DRUG:
BAY1834942
Sponsor
Bayer